About the Background
It is well-known that the overall burden of disease is heavily influenced by smoking, alcohol, unhealthy nutrition and physical inactivity (1) . As a result, there is widespread need for health promotion activities throughout society; in families and at work places, in schools and in institutions and other settings. The need also exists in health care settings, and here too, it is quite substantial in scale; 80-90% of patients have risky lifestyle factors that aggravate their patient pathways (2) . Additionally, strong evidence highlights the significant benefits of health promotion intervention in patient pathways. Applying health promotion activities directly in health care settings means supporting patients to quit daily smoking, control alcohol-drinking and nutrition, and maintain a healthy level of physical activity. Interventions addressing this have been termed "clinical health promotion" (CHP) (3;4) , and have been proven to increase patient safety and improve treatment results in the areas of surgery, internal medicine, obstetrics and psychiatry (5-9) and be cost-effective (10) . Consequently, CHP is a core element in high quality health care (11) (12) (13) in line with other evidence-based clinical interventions.
To facilitate CHP implementation, the World Health Organization (WHO) and the International Network of Health Promoting Hospitals and Health Services (HPH) have developed and validated a set of standards and indicators (14;15) following the International Society for Quality in Health Care criteria (16). Two supplementary models used for practical clinical documentation of CHP needs and services delivered were also developed and validated internationally (17;18) . These models help clinicians and managers with implementation of CHP: namely diagnosing the patients' needs for CHP (e.g daily smoking) and delivering the related interventions (e.g. smoking cessa- work Coordinators, who are asked to present the call to their member hospitals. The call is repeated at the International HPH Conferences each year and in the related scientific journal of Clinical Health Promotion (www.clinhp.org). Participation is approved by each participating hospital's CEO, the head of the participating department and the National/Regional HPH Coordinator.
Inclusion criteria
All clinical hospital departments treating inpatients and/or outpatients are eligible for inclusion; university as well as non-university hospitals with rural, mixed or urban catchment areas, but each included hospital can have only one clinical department participate in the study.
Exclusion criteria
Palliative care departments, paediatric departments, nursing homes, non-hospital clinics, and primary care facilities are excluded, as the WHO standards and the other tools are not yet validated for these types of clinical settings.
Processes, interventions and comparisons
The randomization is computerised using blocks of unknown sizes between 3 to 8. Stratification is done for each participating regional/national HPH Network. The randomisation is performed by an independent researcher, who is not otherwise involved with the study. Randomization envelopes are opaque and sealed by the independent researcher. The allocation was video recorded. The study is by nature not blinded, but all statistical analyses are undertaken by a blinded, independent researcher not otherwise involved in the project.
Outcomes
The outcomes were measured and analysed at department level. The health gain among patients and staff is calculated via health related quality of life using SF-36 health questionnaires for self-reporting on eight dimensions of physical and mental health. This questionnaire has been translated and validated worldwide (22) .
The health promotion deliveries are measured by:
• self-assessment tools: WHO-HPH standards for health promotion in hospitals with a total of 40 measurable elements and 18 indicators provided in a manual (11), the 9-question HPH DATA Model (17) and the 16-deliverable services HPH DOC-ACT Model (18).
• internal audit of 50 medical records, where the tion counselling). These tools have been implemented completely or in part in national or regional health services in several countries including Sweden, Denmark and Ireland.
A general challenge in health care settings is real-life implementation of new evidence for the benefit of patients. This is also the case for CHP (19;20) . Accordingly, it is necessary to develop, describe and evaluate a fast-track implementation program to increase integration speed. Such a fast-track program should build on the commonly used strategies for implementation; such as quality management, staff training and recognition/accreditation.
However, these commonly used strategies have only been sparsely investigated in high quality research designs like randomised trials. Until now, just one study has evaluated the effect of accreditation, but without including health measurements as an outcome (21) .
Methods/design
The aim of the present study is to evaluate the effects of a fast-track program for implementation of CHP on frequency of delivery of CHP services and on health gains of patients and staff.
The main study hypothesis is that clinical hospital departments allocated to the fast-track program for CHP will display improved health gains for their patients and staff after one year, compared to the control group departments that continue usual implementation routines. The secondary hypothesis is that the intervention group departments will display more frequent delivery of CHP services.
The study is a multi-national, randomized trial with two arms. The clinical department is the unit of randomization and measurement -not individual patients. This approach is necessary to test the program's effect on overall organizational performance of the clinical department.
The study takes place in various types of surgical, medical and psychiatric hospital departments.
Material
There is a total of 48 clinical departments participating, 21 
Comparison
The control group departments (CGD) wait ½-1 year after allocation, and they then perform their measurement similar to baseline of IGD. The waiting period reduces possible contamination from results on usual implementation routines. All CGD are offered support to use the fast-track implementation program after the IGD have finalized their implementation period.
Data collection
All data collected are anonymized locally at the source. No type of person-identifiable information is transferred. Reported data from participating centres is in electronic or paper format. Upon receipt by research group and initial data validation, all data is entered into the electronic project databases using numeric codes. All data is stored on an internal hospital drive, secured by Capital Region Denmark CIMT to avoid risk of data loss. Only project staff and researchers have access to the anonymous database and archives.
SF-36
The health status at each department is based on data collected from up to 200 consecutive patients, who visit the department in the month immediately prior to inclusion in the study. If 200 patients are not seen in that particular month, the department only includes the patients of that month. Data from all staff employed in the department (at any point) during the same month are also collected.
WHO HPH standards
The self-assessment of CHP delivery is done with a total of 40 measurable elements and 18 indicators provided in the WHO HPH standards manual (11) ( Table 1) .
The WHO HPH standards cover 5 areas:
1. policy for health promotion 2. patient needs assessment 3. patient information and intervention 4. creation of a healthy workplace 5. continuity and collaboration with outside providers and other sectors
HPH DATA Model
The HPH Data Model is used for practical clinical assessment and documentation of patient needs for CHP services. It fits directly into WHO HPH standard 2 (above), and precedes the HPH DOC-ACT Model below. It is used for internal audit of 50 consecutive and anonymized medical records on patients in contact with IGD and CGD. The period assessed is one month before inclusion corresponding to the measurement of HPH DATA Model is used for practical clinical assessment of patient needs for CHP services and the HPH DOC-ACT Model for assessment of CHP service delivery.
Intervention
After allocation, the intervention group departments (IGD) measure their baseline CHP performance and health status of patients and staff (see data collection, below). After measuring, IGD produce a quality plan for CHP according to the fast-track program and based on analysis of own baseline results. The quality plan is then implemented over 1 year, at which point CHP performance and health status are re-measured in the same way as for baseline -and followed by a site visit for validation ( Figure 1 ). 
Inclusion of 48 clinical departments

HPH DOC-ACT Model
This model is used for assessment and documentation of patient-related CHP service deliveries, either as short face-to-face intervention or as the longer and more intensive interventions with repeated meetings. This model fits into standard 3 (above), and it follows the HPH DATA Model. The model includes 2x8 CHP activities, table 3. Clinical specialists responsible for coding treatment in the clinical setting have found the model understandable, applicable and adequate (18) . The data collection is performed as described above for the HPH DATA Model. SF-36 above. It continues backwards until 50 medical records are obtained. The HPH DATA Model comprises 9 questions that cover the 5 main risk factors (smoking, risky drinking, overweight/obesity, malnutrition and physical inactivity) influencing the treatment results of the patients. The model has been shown to be easy to understand and use, with a low inter-variation in the clinical setting (17), (table 2). 
Quality plan
The template for making the required CHP quality plan for fast track implementation follows the traditional instructions for quality assurance and is shown in figure  2 . The department's own data is the base for formulating the quality plan, milestones, actions and 1-year timeline. Minor adjustments to the plan are allowed and often necessary according to changes in hospital structure, patient group and staff in order to reach the milestones (Figure 2 ).
Follow-up
After the 1-year implementation, the baseline measurements are repeated for IGD, but this time covering the period of the month immediately following the 1-year implementation.
Data validation through site visit
The study participation for IGD concludes with a site visit that takes place after collection of follow-up data. The site visit focuses on validation of results on the WHO-HPH standards. The visit entails interviews with the staff and patients as well as an external audit of about 5 random medical records together with the local medical staff (and a trained interpreter in case of non-English language) to validate the internal data collection. At the visit, a certificate is issued outlining fulfilment of the WHO HPH standards, exclusively. 
Baseline Status
Here, please use the main results from the data collection. We advice that your mark each item in colours (green, yellow and red) according to the inherent room for improvement, so that green items are areas that are ok already, yellow are areas in need of some improvement and red are areas in need of significant improvement. 
MR Audit Form
Discussion
This is going to be the first randomized study on a fasttrack implementation strategy to include health gain as an outcome in addition to service deliveries. The focus is on integrating health promotion into the clinical treatment in order to obtain better treatment results and prognoses on short as well as longer term. The improved outcomes of individual programs at patient-level are already shown for patients in e.g. internal medicine, surgery, psychiatry and obstetrics (23;24) . The education of staff members to improve CHP service delivery, and regarding their own health as such, are also important in this work, along with collaboration across departments and sectors.
Status
Until now, the first baseline data on the WHO HPH standards have shown variation in fulfilment of the 40 elements between hospital departments (Taiwan and the Czech Republic), leaving room for improvement. Our main outcomes of health gain and CHP deliveries has not yet been published as the study has not finalised yet.
The first departments were recruited in 2012, and by October 2015, 48 departments had been included. At that time, it was made official that WHO Europe would conduct a 2016 update and revision of the WHO standards for health promotion in hospitals (11) . Therefore, the inclusion for this present study was halted prematurely at the 48 already included departments (representing 60% of the intended 80 departments), since the WHO standards are a main tool used in the study's data collection.
A main issue has been logistics and time consumption around project agreement by departments, which had to be signed by the department head and hospital director before inclusion. Also, several delays with data submissions have been experienced.
Bias and limitations
While the real-life conditions set-up is a strength, it is a limitation that all clinical departments included in the study are from HPH Network member hospitals, which
Statistical analyses
The analyses will be conducted at department level and comparisons are made between IGD and CGD using intention-to-treat. The data is presented as median and range (but also as mean and SD for easy use in case of future meta-analysis). The health status from SF-36 will be analyzed with Mann-Whitney test, while frequencies will be compared by Fisher's exact test. An external researcher blinded for group allocation will conduct all analyses on the anonymized data using StataCorp LP's STATA 14 statistics software. P-value below 0.05 is considered significant.
Since no studies have been performed hitherto on health gain in this context, it would be difficult to make a meaningful power calculation for this primary outcome. However, looking for a minimum relevant difference of about 1/3, the calculation of the secondary outcome below should be sufficient -also for the health gain analyses. The power calculation of the secondary outcome is based on the literature, assuming that frequency of CHP service deliveries is no higher than 40% of the needed (control departments π2=0.4) (18) . With a minimum relevant difference in deliveries of CHP services of 30 % (δ=0.3) between the intervention and control groups, the expected outcome is 70 % (intervention departments π1= 0.7). Accordingly, 40 departments would be needed in each arm, considering 80% power and 5% two-sided significance.
Nevertheless, full inclusion for this study has not been reached before a scheduled update and revision of the WHO standards in 2016.
Organization
Clinical Health Promotion Centre, Bispebjerg-Frederiksberg Hospital, Copenhagen University, is responsible for project organization, data collection and administration and is in close collaboration with the participating Coordinators from the National/Regional HPH Network, the hospital managements, the heads of departments and the local HPH Hospital Coordinators. The National/Regional HPH Coordinators and the hospital HPH Coordinators are responsible for project support, while the hospitals' managements and heads of department are responsible for local project progress, collection of data, quality plan and implementation.
The project is approved by Copenhagen University as part of the PHD study for Jeff Kirk Svane, who is supervised by Professor Hanne Tønnesen (Main Supervisor; Copenhagen) and Professor Shu-Ti Chiou (Co-Supervisor; Taipei). Professor Oliver Groene (London) is International Project Advisor.
might reduce the generalization to non-HPH hospital settings. Furthermore, it should be noted that all data are collected by self-assessment and self-reporting, which may introduce selective reporting biases with overestimation of performance.
The reduced number of participants will introduce a high risk of a type-2 error, and thereby risk of overlooking results that could have been of significance if the planned sizeable study was completed. However, even a sizeable study could not reduce a risk of type-1 error, which would require repetition of the study. It is a strength to report the results in accordance with the level of randomization (i.e. at department level), thus avoiding the further bias introduced by potential cluster randomization.
Plan
During 2016, all remaining in-coming data from the hospital departments will be collected, analyses conducted and results made public.
Abbrevations
• CHP: Clinical health promotion (incl. smoking cessation support for daily smokers, alcohol cessation support for excessive drinkers, nutritional support for obese or malnourished patients and physical activity support for the physically inactive). 
Ethical considerations
Participation will not cause departments, their patients or their staff any risk. However, it will entail approximately 100 hours of staff time per participating IGD and 50 hours per CGD. This resource allocation seems ethically balanced by the potentially possible improvement in health gain and CHP deliveries for the benefit of the patients and staff. Participation in the study only takes place after informed consent before inclusion by the involved hospital management, the head of the participating department, the National/Regional HPH Coordinator, and the local hospital HPH Coordinator. Also, the utilized components are already validated and implemented or being implemented, in part of in full, in several hospitals all over the world (see www.hphnet.org).
Ethical approval for this study was obtained from the Scientific Ethical Committee in the Danish Capital Region (International Studies) and Danish Data protection Agency (J.nr.2012-41-0152). Approval is also obtained by all relevant national/regional/local ethical and research authorities (such as internal review boards) as per the regulations and requirements in each hospital/ region/nation.
The intervention is conducted without following any individual patient or staff member, with all data anonymized at the source (at data collection) before transferal and storage at WHO-CC in secured files with access for the research team only -in order to fully guarantee confidentiality and security. 
